Piper Sandler lowered the firm’s price target on Elanco (ELAN) to $12 from $16 following the company’s earnings report. The firm keeps a Neutral rating on the shares.
Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ELAN:
- Elanco Animal Health: Undervalued Growth Potential with Strong Product Performance and Debt Reduction
- Elanco’s Earnings Call: Growth Amid Challenges
- Cautious Hold Rating on Elanco Animal Health Amid Uncertain Growth Prospects
- Elanco price target lowered to $13 from $14 at Morgan Stanley
- Elanco price target lowered to $15 from $16 at Stifel